PL2251330T3 - 4-hydroksybenzomorfany - Google Patents

4-hydroksybenzomorfany

Info

Publication number: PL2251330T3
Authority: PL; Poland
Prior art keywords: hydroxybenzomorphans; thiocarboxamide; antitussives; anticonvulsants; analgesics
Prior art date: 2004-11-05

Application number

PL10008474T

Other languages

English (en)

Inventor

Mark P Wentland

Original Assignee

Rensselaer Polytech Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-11-05

Filing date

2005-11-03

Publication date

2012-12-31

2005-11-03 Application filed by Rensselaer Polytech Inst filed Critical Rensselaer Polytech Inst

2012-12-31 Publication of PL2251330T3 publication Critical patent/PL2251330T3/pl

Links

206010012335 Dependence Diseases 0.000 abstract 1
229940035676 analgesics Drugs 0.000 abstract 1
230000000954 anitussive effect Effects 0.000 abstract 1
239000000730 antalgic agent Substances 0.000 abstract 1
229940125681 anticonvulsant agent Drugs 0.000 abstract 1
239000001961 anticonvulsive agent Substances 0.000 abstract 1
229940125714 antidiarrheal agent Drugs 0.000 abstract 1
239000003793 antidiarrheal agent Substances 0.000 abstract 1
239000003434 antitussive agent Substances 0.000 abstract 1
229940124584 antitussives Drugs 0.000 abstract 1
125000003917 carbamoyl group Chemical class [H]N([H])C(*)=O 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000002483 medication Methods 0.000 abstract 1
CYEBJEDOHLIWNP-UHFFFAOYSA-N methanethioamide Chemical compound NC=S CYEBJEDOHLIWNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/26—Benzomorphans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Immunology (AREA)
Pulmonology (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Child & Adolescent Psychology (AREA)
Obesity (AREA)
Transplantation (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Hematology (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Hydrogenated Pyridines (AREA)

PL10008474T 2004-11-05 2005-11-03 4-hydroksybenzomorfany PL2251330T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US62534804P	2004-11-05	2004-11-05
EP05851351A EP1817291A1 (en)	2004-11-05	2005-11-03	4-hydroxybenzomorphans
EP10008474A EP2251330B1 (en)	2004-11-05	2005-11-03	4-Hydroxybenzomorphans

Publications (1)

Publication Number	Publication Date
PL2251330T3 true PL2251330T3 (pl)	2012-12-31

Family

ID=36128632

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL10008474T PL2251330T3 (pl)	2004-11-05	2005-11-03	4-hydroksybenzomorfany

Country Status (20)

Country	Link
US (7)	US7262298B2 (pl)
EP (2)	EP2251330B1 (pl)
JP (3)	JP5198067B2 (pl)
KR (1)	KR101115841B1 (pl)
CN (1)	CN101090891B (pl)
AT (1)	ATE557006T1 (pl)
AU (1)	AU2005304950B2 (pl)
BR (1)	BRPI0517091B8 (pl)
CA (1)	CA2587074C (pl)
CY (1)	CY1112946T1 (pl)
DK (1)	DK2251330T3 (pl)
ES (1)	ES2387737T3 (pl)
IL (1)	IL182983A (pl)
MX (1)	MX2007005389A (pl)
NO (1)	NO340204B1 (pl)
PL (1)	PL2251330T3 (pl)
PT (1)	PT2251330E (pl)
RU (2)	RU2415131C2 (pl)
SI (1)	SI2251330T1 (pl)
WO (1)	WO2006052710A1 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE292625T1 (de) *	2000-10-31	2005-04-15	Rensselaer Polytech Inst	8-substituierte 2,6-methano-3-benzazocine und 3- substituierte morphinane als opioidrezeptorbindende agenzien
US7262298B2 (en) *	2004-11-05	2007-08-28	Rensselaer Polytechnic Institute	4-hydroxybenzomorphans
AU2006272773B2 (en)	2005-07-21	2012-03-08	Rensselaer Polytechnic Institute	8-carboxamido-substituted-2 , 6-methano-3-benzazocines and 3 - carboxamido- substituted morphanes as opioid receptor binding agents
ATE493416T1 (de)	2007-05-04	2011-01-15	Mallinckrodt Inc	Verbessertes verfahren zur herstellung von 6- alpha-hydroxy-n-alkylierten opiaten
JP2010533719A (ja)	2007-07-17	2010-10-28	マリンクロッド・インコーポレイテッド	還元的アミノ化によるｎ−アルキル化オピエートの調製
WO2009023567A1 (en)	2007-08-09	2009-02-19	Rensselaer Polytechnic Institute	Quaternary opioid carboxamides
CA2738628C (en)	2008-09-30	2017-07-04	Mallinckrodt Inc.	Processes for the selective amination of ketomorphinans
US8946419B2 (en)	2009-02-23	2015-02-03	Mallinckrodt Llc	(+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
WO2010107457A1 (en) *	2009-03-19	2010-09-23	Alkermes, Inc.	Morphinan derivatives with high oral bioavailability
WO2010118274A1 (en) *	2009-04-09	2010-10-14	Mallinckrodt Inc.	Preparation of 6-keto, 3-alkoxy morphinans
US8471023B2 (en)	2009-06-11	2013-06-25	Mallinckrodt Llc	Reductive amination of 6-keto normorphinans by catalytic hydrogen transfer
CA2764915C (en)	2009-06-11	2017-07-11	Mallinckrodt Llc	Preparation of 6-alpha-amino n-substituted morphinans by catalytic hydrogen transfer
HUE043963T2 (hu) *	2009-12-04	2019-09-30	Alkermes Pharma Ireland Ltd	Morfinán származékok gyógyszer-túladagolás kezelésére
WO2011119605A2 (en)	2010-03-22	2011-09-29	Rensselaer Polytechnic Institute	Carboxamide biosiosteres of opiates
WO2011137086A1 (en) *	2010-04-29	2011-11-03	Mallinckrodt Llc	Preparation of saturated ketone morphinan compounds having low metal content
WO2012005795A1 (en)	2010-07-08	2012-01-12	Alkermes, Inc.	Process for the synthesis of substituted morphinans
EP2608670B1 (en)	2010-08-23	2018-10-31	Alkermes Pharma Ireland Limited	Methods for treating antipsychotic-induced weight gain
US9029543B2 (en)	2011-04-05	2015-05-12	Alkermes, Inc.	Process for the synthesis of quaternary amine compounds
ES2698408T3 (es)	2011-06-09	2019-02-04	SpecGx LLC	Aminación reductora de 6-ceto morfinanos por transferencia de hidrógeno catalítico
CA2840643C (en)	2011-06-29	2017-11-21	Alkermes, Inc.	Peripherally acting opioid compounds
KR20140063763A (ko)	2011-09-08	2014-05-27	말린크로트 엘엘씨	중간체를 단리하지 않는 알칼로이드의 제조 방법
SMT201800664T1 (it)	2011-12-15	2019-01-11	Alkermes Pharma Ireland Ltd	Samidorphan (alks 33) in combinazione con buprenorfina per il trattamento di disturbi depressivi
US9211293B2 (en)	2011-12-15	2015-12-15	Alkermes Pharma Ireland Limited	Opioid agonist antagonist combinations
ES2770978T3 (es)	2013-05-24	2020-07-06	Alkermes Pharma Ireland Ltd	Análogos de morfanos y morfinanos y métodos de uso
US9656961B2 (en)	2013-05-24	2017-05-23	Alkermes Pharma Ireland Limited	Methods for treating depressive symptoms
KR20190120212A (ko) *	2017-03-02	2019-10-23	가부시키가이샤산와카가쿠켄큐쇼	알코올 사용 장해의 치료약
CN107089948B (zh) *	2017-04-28	2020-07-17	云南大学	吗吩衍生物及其制备方法和应用
CN111978252A (zh) *	2019-05-21	2020-11-24	复旦大学	手性苯并吗吩烷类衍生物及其制备方法和在药学上的应用
TW202140009A (zh) *	2020-02-13	2021-11-01	大陸商上海翰森生物醫藥科技有限公司	３－甲醯胺基－４－羥基納曲酮氘代衍生物、其製備方法及其在醫藥上的應用
CN111205151B (zh) *	2020-02-29	2021-03-05	深圳市祥根生物科技有限公司	一种布洛芬杂质i的环保制备方法
WO2022101444A1 (en)	2020-11-12	2022-05-19	Alkermes Pharma Ireland Limited	Immediate release multilayer tablet
CN114621238B (zh) *	2020-12-10	2026-02-03	鲁南制药集团股份有限公司	一种制备纳呋拉啡的方法
KR102663533B1 (ko) *	2021-11-09	2024-05-08	백미선	레이저 치료기기용 온냉각장치

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3957793A (en) *	1974-09-20	1976-05-18	Sterling Drug Inc.	Hydroxyiminobenzazocines
US4032529A (en) *	1974-09-20	1977-06-28	Sterling Drug Inc.	Aminomethanobenzazocine intermediates
SU635868A3 (ru) *	1974-11-12	1978-11-30	Бристол Мейерз Компани (Фирма)	Способ получени морфиновых производных или их солей
US4205171A (en) *	1976-01-12	1980-05-27	Sterling Drug Inc.	Aminomethanobenzazocines and nitromethanobenzazocines
US4373139A (en) *	1979-04-30	1983-02-08	Motorola, Inc.	Detectors
US4649200A (en) *	1986-05-08	1987-03-10	Regents Of The University Of Minnesota	Substituted pyrroles with opioid receptor activity
EP0632041A1 (en)	1993-07-01	1995-01-04	Katholieke Universiteit Nijmegen	New morphine derivatives having improved analgesic and narcotic properties
HUP9900974A3 (en)	1996-01-10	2000-09-28	Smithkline Beecham Spa	Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
ATE292625T1 (de) *	2000-10-31	2005-04-15	Rensselaer Polytech Inst	8-substituierte 2,6-methano-3-benzazocine und 3- substituierte morphinane als opioidrezeptorbindende agenzien
WO2004007449A1 (en) *	2002-07-16	2004-01-22	Rensselaer Polytechnic Institute	Process for conversion of phenols to carboxamides via the succinimide esters
US7262298B2 (en) *	2004-11-05	2007-08-28	Rensselaer Polytechnic Institute	4-hydroxybenzomorphans

2005
- 2005-11-03 US US11/266,651 patent/US7262298B2/en not_active Expired - Lifetime
- 2005-11-03 JP JP2007540055A patent/JP5198067B2/ja not_active Expired - Lifetime
- 2005-11-03 EP EP10008474A patent/EP2251330B1/en not_active Expired - Lifetime
- 2005-11-03 EP EP05851351A patent/EP1817291A1/en not_active Withdrawn
- 2005-11-03 AU AU2005304950A patent/AU2005304950B2/en not_active Expired
- 2005-11-03 BR BRPI0517091A patent/BRPI0517091B8/pt active IP Right Grant
- 2005-11-03 PT PT10008474T patent/PT2251330E/pt unknown
- 2005-11-03 CA CA2587074A patent/CA2587074C/en not_active Expired - Lifetime
- 2005-11-03 AT AT10008474T patent/ATE557006T1/de active
- 2005-11-03 WO PCT/US2005/039911 patent/WO2006052710A1/en not_active Ceased
- 2005-11-03 CN CN2005800451698A patent/CN101090891B/zh not_active Expired - Lifetime
- 2005-11-03 KR KR1020077012582A patent/KR101115841B1/ko not_active Expired - Lifetime
- 2005-11-03 MX MX2007005389A patent/MX2007005389A/es active IP Right Grant
- 2005-11-03 PL PL10008474T patent/PL2251330T3/pl unknown
- 2005-11-03 DK DK10008474.8T patent/DK2251330T3/da active
- 2005-11-03 RU RU2007120759/04A patent/RU2415131C2/ru active
- 2005-11-03 RU RU2010147915/04A patent/RU2480455C2/ru active
- 2005-11-03 SI SI200531549T patent/SI2251330T1/sl unknown
- 2005-11-03 ES ES10008474T patent/ES2387737T3/es not_active Expired - Lifetime
2007
- 2007-05-03 IL IL182983A patent/IL182983A/en active IP Right Grant
- 2007-06-04 NO NO20072839A patent/NO340204B1/no unknown
- 2007-06-08 US US11/760,039 patent/US8680112B2/en active Active
2012
- 2012-07-31 CY CY20121100677T patent/CY1112946T1/el unknown
- 2012-11-22 JP JP2012256445A patent/JP6058981B2/ja not_active Expired - Lifetime
2013
- 2013-04-15 US US13/862,975 patent/US20130231361A1/en not_active Abandoned
2014
- 2014-01-31 US US14/169,305 patent/US8802655B2/en not_active Expired - Lifetime
- 2014-07-02 US US14/321,885 patent/US20150011768A1/en not_active Abandoned
2015
- 2015-04-27 US US14/697,013 patent/US20160075658A1/en not_active Abandoned
- 2015-08-12 JP JP2015159733A patent/JP2016020364A/ja active Pending
2023
- 2023-04-17 US US18/301,336 patent/US20240092740A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ATE557006T1 (de)	2012-05-15
DK2251330T3 (da)	2012-08-06
EP2251330B1 (en)	2012-05-09
RU2480455C2 (ru)	2013-04-27
AU2005304950A1 (en)	2006-05-18
EP2251330A1 (en)	2010-11-17
IL182983A0 (en)	2007-08-19
CY1112946T1 (el)	2016-04-13
ES2387737T3 (es)	2012-10-01
BRPI0517091A (pt)	2008-09-30
JP6058981B2 (ja)	2017-01-11
NO20072839L (no)	2007-08-03
CA2587074C (en)	2012-09-04
US20240092740A1 (en)	2024-03-21
US7262298B2 (en)	2007-08-28
RU2415131C2 (ru)	2011-03-27
US20140148475A1 (en)	2014-05-29
WO2006052710A1 (en)	2006-05-18
US20150011768A1 (en)	2015-01-08
CA2587074A1 (en)	2006-05-18
MX2007005389A (es)	2007-12-07
CN101090891B (zh)	2012-08-01
US20070238748A1 (en)	2007-10-11
US20060111384A1 (en)	2006-05-25
RU2010147915A (ru)	2012-05-27
CN101090891A (zh)	2007-12-19
NO340204B1 (no)	2017-03-20
BRPI0517091B1 (pt)	2019-10-08
KR20070085723A (ko)	2007-08-27
AU2005304950B2 (en)	2010-12-09
US8680112B2 (en)	2014-03-25
SI2251330T1 (sl)	2012-09-28
JP2013067636A (ja)	2013-04-18
IL182983A (en)	2012-06-28
JP2016020364A (ja)	2016-02-04
PT2251330E (pt)	2012-07-20
US20160075658A1 (en)	2016-03-17
JP5198067B2 (ja)	2013-05-15
US8802655B2 (en)	2014-08-12
US20130231361A1 (en)	2013-09-05
KR101115841B1 (ko)	2012-03-09
JP2008519035A (ja)	2008-06-05
RU2007120759A (ru)	2008-12-10
BRPI0517091B8 (pt)	2021-05-25
EP1817291A1 (en)	2007-08-15

Publication	Publication Date	Title
IL182983A0 (en)	2007-08-19	4-hydroxybenzomorphans
USD782697S1 (en)	2017-03-28	Rail
IL181964A0 (en)	2007-07-04	Medicaments comprising carbonyl compounds, and the use thereof
ZA200502247B (en)	2005-09-19	Selected CGRP antagonists, method for production and use thereof as medicament.
IL174635A0 (en)	2006-08-20	Fibrosis-inducing agents, compositions containing the same and intravascular devices containing the same
ZA200407813B (en)	2005-10-18	Medicament for preventing and/or treating chronic rejection.
IL162669A0 (en)	2005-11-20	Antichlinergic agents, method for producing the same and use thereof as medicaments
GB0409558D0 (en)	2004-06-02	Particulate emulsifiers,emulsions and uses thereof
ZA200306483B (en)	2004-02-10	Gaming machine and server therefor.
AP2005003461A0 (en)	2005-12-31	Sonic heads and assemblies and uses thereof.
PL394604A1 (pl)	2011-07-18	Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna
WO2004031352A3 (en)	2006-03-16	Interferon variants with improved properties
ZA200400313B (en)	2004-11-01	Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine.
AU2003272260A8 (en)	2004-03-29	Verifiable absorption drug delivery form based on cyclodextrins
ZA200500219B (en)	2005-10-27	Modified bryodin 1 with reduced immunogenicity.
ZA200408787B (en)	2005-10-20	Pharmaceutical combination.
GB0312340D0 (en)	2003-07-02	Improved game and aricle for use with the game
ITBO20040403A1 (it)	2004-09-25	Riduttore di velocita', particolarmente per estrusori, e simili
EP1829860A4 (en)	2011-06-08	9,10-SECOPREGNANDERIVAT AND MEDICINE
PL114818U1 (en)	2004-11-02	V .03
ZA200201853B (en)	2002-12-24	Homogeniser.
ITGE20030111A1 (it)	2005-06-25	Anta, in particolare per armadi e simili.
ZA200406360B (en)	2005-06-13	"An operating system for use with winch and conveyor arrangements.
ITPD20030307A1 (it)	2005-06-24	Slamatore con bloccaggio dell'amo
IT248493Y1 (it)	2003-02-04	Anta sagomata per mobili e simili.